Lee F. Allen M.D. Ph.D., Chief Medical Officer at Dova Pharmaceuticals Inc. (DOVA), sold 978 shares at $28.00 ($27K) on 2019-09-30, disclosed to the SEC on 2019-10-02.
Scheduled sale ($27k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| AMAG | BUY | 2011-12-02 | $4K | — | Filing → |
| AMAG | SELL | 2011-08-12 | $29K | — | Filing → |
| AMAG | BUY | 2011-06-01 | $17K | — | Filing → |